These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24862765)

  • 1. English cross-cultural translation and validation of the neuromuscular score: a system for motor function classification in patients with neuromuscular diseases.
    Vuillerot C; Meilleur KG; Jain M; Waite M; Wu T; Linton M; Datsgir J; Donkervoort S; Leach ME; Rutkowski A; Rippert P; Payan C; Iwaz J; Hamroun D; Bérard C; Poirot I; Bönnemann CG
    Arch Phys Med Rehabil; 2014 Nov; 95(11):2064-2070.e1. PubMed ID: 24862765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a motor function classification in patients with neuromuscular disease: the NM-score.
    Vuillerot C; Rippert P; Roche S; Bérard C; Margirier F; de Lattre C; Poirot I; Berruyer A; Tiffreau V; Fournier-Mehouas M; Bouhour F; Urtizberea JA; Renders A; Ecochard R;
    Ann Phys Rehabil Med; 2013 Dec; 56(9-10):673-86. PubMed ID: 24231198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turkish version of the Motor Function Measure Scale (MFM-32) forneuromuscular diseases: a cross-cultural adaptation, reliability, and validity study.
    İnal HS; Tarakçı E; Tarakçı D; Aksoy G; Mergen Kılıç S; Beşer H; Beşer Ç; Özdinçler AR; Durmuş Tekçe H; Parman FY; Deymeer F; Oflazer ZP
    Turk J Med Sci; 2017 Dec; 47(6):1826-1833. PubMed ID: 29306245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Validity of the motor function measurement scale when routinely used in the follow-up of adult outpatients in a neuromuscular center].
    Benaïm C; Sacconi S; Fournier-Mehouas M; Tanant V; Desnuelle C
    Rev Neurol (Paris); 2010 Jan; 166(1):49-53. PubMed ID: 19524275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rasch analysis of the motor function measure in patients with congenital muscle dystrophy and congenital myopathy.
    Vuillerot C; Rippert P; Kinet V; Renders A; Jain M; Waite M; Glanzman AM; Girardot F; Hamroun D; Iwaz J; Ecochard R; Quijano-Roy S; Bérard C; Poirot I; Bönnemann CG;
    Arch Phys Med Rehabil; 2014 Nov; 95(11):2086-95. PubMed ID: 24973498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a two-year pilot study of clinical outcome measures in collagen VI- and laminin alpha2-related congenital muscular dystrophies.
    Meilleur KG; Jain MS; Hynan LS; Shieh CY; Kim E; Waite M; McGuire M; Fiorini C; Glanzman AM; Main M; Rose K; Duong T; Bendixen R; Linton MM; Arveson IC; Nichols C; Yang K; Fischbeck KH; Wagner KR; North K; Mankodi A; Grunseich C; Hartnett EJ; Smith M; Donkervoort S; Schindler A; Kokkinis A; Leach M; Foley AR; Collins J; Muntoni F; Rutkowski A; Bönnemann CG
    Neuromuscul Disord; 2015 Jan; 25(1):43-54. PubMed ID: 25307854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsiveness and Minimal Clinically Important Difference of the Motor Function Measure in Collagen VI-Related Dystrophies and Laminin Alpha2-Related Muscular Dystrophy.
    Le Goff L; Meilleur KG; Norato G; Rippert P; Jain M; Fink M; Foley AR; Waite M; Donkervoort S; Bönnemann CG; Vuillerot C
    Arch Phys Med Rehabil; 2021 Apr; 102(4):604-610. PubMed ID: 33166523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responsiveness of the motor function measure in patients with spinal muscular atrophy.
    Vuillerot C; Payan C; Iwaz J; Ecochard R; Bérard C;
    Arch Phys Med Rehabil; 2013 Aug; 94(8):1555-61. PubMed ID: 23380348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper extremity outcome measures for collagen VI-related myopathy and LAMA2-related muscular dystrophy.
    Bendixen RM; Butrum J; Jain MS; Parks R; Hodsdon B; Nichols C; Hsia M; Nelson L; Keller KC; McGuire M; Elliott JS; Linton MM; Arveson IC; Tounkara F; Vasavada R; Harnett E; Punjabi M; Donkervoort S; Dastgir J; Leach ME; Rutkowski A; Waite M; Collins J; Bönnemann CG; Meilleur KG
    Neuromuscul Disord; 2017 Mar; 27(3):278-285. PubMed ID: 28087121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A motor function measurement scale for neuromuscular diseases - description and validation study].
    Bérard C; Payan C; Fermanian J; Girardot F;
    Rev Neurol (Paris); 2006 Apr; 162(4):485-93. PubMed ID: 16585909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor function measure: validation of a short form for young children with neuromuscular diseases.
    de Lattre C; Payan C; Vuillerot C; Rippert P; de Castro D; Bérard C; Poirot I;
    Arch Phys Med Rehabil; 2013 Nov; 94(11):2218-26. PubMed ID: 23602884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A motor function measure for neuromuscular diseases. Construction and validation study.
    Bérard C; Payan C; Hodgkinson I; Fermanian J;
    Neuromuscul Disord; 2005 Jul; 15(7):463-70. PubMed ID: 16106528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a muscular dystrophy-specific functional rating scale.
    Lue YJ; Su CY; Yang RC; Su WL; Lu YM; Lin RF; Chen SS
    Clin Rehabil; 2006 Sep; 20(9):804-17. PubMed ID: 17005504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI Assessment of Motor Capabilities in Patients with Duchenne Muscular Dystrophy According to the Motor Function Measure Scale.
    Suslov V; Suslova G; Lytaev S
    Tomography; 2022 Apr; 8(2):948-960. PubMed ID: 35448710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Systemic Sclerosis Questionnaire (SySQ): Validation of the translation of the original German version into Spanish and its relationship to the disease and to quality of life.
    Cruz-Domínguez MP; Casarrubias-Ramírez M; Gasca-Martínez V; Maldonado García C; Carranza-Muleiro RA; Medina G; García-Collinot G; Montes-Cortes DH
    Reumatol Clin (Engl Ed); 2019; 15(5):282-288. PubMed ID: 29241641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reliability and validity of the Turkish version of fibromyalgia survey diagnostic criteria and symptom severity scale.
    Yanmaz MN; Atar S; Biçer M
    J Back Musculoskelet Rehabil; 2016 Apr; 29(2):287-293. PubMed ID: 26406206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing the cross-cultural adaptation and validation process: linguistic and psychometric testing of the Brazilian-Portuguese version of a self-report measure for dry eye.
    Santo RM; Ribeiro-Ferreira F; Alves MR; Epstein J; Novaes P
    J Clin Epidemiol; 2015 Apr; 68(4):370-8. PubMed ID: 25619561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Criterion validity of the spatial exploration test of upper limb mobility to evaluate the active horizontal workspace of children with spinal muscular atrophy.
    Pruvost S; Gomez Garcia de la Banda M; Quijano Roy S; Izedaren F; Roche N; Pouplin S
    Disabil Rehabil; 2024 Feb; 46(3):575-580. PubMed ID: 36650958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcultural adaptation and validation of the Spanish-language version of ACTIVLIM in adults with inherited myopathies using the Rasch model.
    Pagola I; Torné L; Jericó I; Ibáñez B
    Neurologia (Engl Ed); 2021 Sep; 36(7):514-524. PubMed ID: 34537165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-cultural validation of the Persian version of the Functional Independence Measure for patients with stroke.
    Naghdi S; Ansari NN; Raji P; Shamili A; Amini M; Hasson S
    Disabil Rehabil; 2016; 38(3):289-98. PubMed ID: 25885666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.